Skip to content
MedsAcross

Medicine

Flavalta 0.017 mg/34 mg per 1.7 mL injection

Epinephrine and Lidocaine · Submucosal · Septodont
Available on requestPrescription onlyUS FDA

Flavalta 0.017 mg/34 mg per 1.7 mL injection is a prescription medicine containing Epinephrine and Lidocaine for submucosal use, marketed by Septodont, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Do not freeze. Other causes of leakage and breakage include badly worn…

Key facts

Active ingredient (INN)
Epinephrine and Lidocaine
Brand
Flavalta
Strength
0.017 mg/34 mg per 1.7 mL
Dosage form
Injection
Route
Submucosal
Packs
50 cartridges of 1.7 mL
Marketing authorisation holder
Septodont
Manufacturer
Septodont
Origin register
US FDA, United States
Storage
Do not freeze. Other causes of leakage and breakage include badly worn syringes, aspirating syringes with bent harpoons, the use of syringes not designed to take 1.7 mL cartridges, and inadvertent freezing. Store at 20° - 25°C (68° - 77°F). Excursions between 15° and 30°C (59° and 86°F) are allowed. Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
19 March 2026
Identifiers
RxCUI 1293648, 2739501DailyMed set ID 3f9f9b4f-bf6c-4b57-ac1a-98fd1a9a369dNDC 0362-1200Application NDA216564

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
50 cartridge in 1 carton / 1.7 mL in 1 cartridge0362-1200-50Septodont19 March 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 19 November 1948Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Epinephrine and Lidocaine 0.017 mg/34 mg per 1.7 mL injection.

Compare all 2

Other strengths and forms of Epinephrine and Lidocaine

Clinical summary

Epinephrine and Lidocaine is a fixed-dose combination of an amide local anesthetic, an antiarrhythmic and a catecholamine. It is available as injection for infiltration, perineural and submucosal use. MedsAcross supplies Epinephrine and Lidocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Epinephrine and Lidocaine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Flavalta 0.017 mg/34 mg per 1.7 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.